Skip to main content
. Author manuscript; available in PMC: 2012 Jun 6.
Published in final edited form as: Pediatr Blood Cancer. 2010 Dec 23;56(5):777–782. doi: 10.1002/pbc.22951

Fig. 1.

Fig. 1

(A) The change in TCD velocity following initiation of transfusion therapy for abnormal TCD is shown for all children (■), children who converted to normal TCD (▲) and children who never converted to normal TCD (□). Follow-up was censored at the time of randomization into the STOP 2 trial (17 subjects). (B) The change in TCD velocity over time from the prior value (three months before) is shown in the box and whisker plot (N = 88).